irinotecan has been researched along with Graves Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Jong, FA; Loos, WJ; Mathijssen, RH; Planting, AS; Schellens, JH; van Aken, MO; van der Bol, JM; Verweij, J; Visser, TJ; Wiemer, EA | 1 |
1 other study(ies) available for irinotecan and Graves Disease
| Article | Year |
|---|---|
Effects of methimazole on the elimination of irinotecan.
Topics: Antineoplastic Agents, Phytogenic; Antithyroid Agents; Camptothecin; Colorectal Neoplasms; Drug Interactions; Glucuronides; Glucuronosyltransferase; Graves Disease; Humans; Irinotecan; Male; Methimazole; Middle Aged | 2011 |